Compugen Ltd. Share Price Deutsche Boerse AG
Stocks
CW9
IL0010852080
Biotechnology & Medical Research
| Market Cap | 201M 179M 167M 152M 287M 19.44B 288M 2.01B 787M 9.91B 754M 738M 31.8B | P/E 2026 * |
-7.57x | P/E 2027 * | -7.68x |
|---|---|---|---|---|---|
| Enterprise Value | 201M 179M 167M 152M 287M 19.44B 288M 2.01B 787M 9.91B 754M 738M 31.8B | EV / Sales 2026 * |
21.7x | EV / Sales 2027 * | 25.9x |
| Free-Float |
99.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compugen Ltd.
| 1 day | -2.88% |
| Manager | Title | Age | Since |
|---|---|---|---|
Eran Ophir
CEO | Chief Executive Officer | - | 22/09/2025 |
David Silberman
DFI | Director of Finance/CFO | 42 | 14/08/2024 |
Pierre Ferre
COO | Chief Operating Officer | 49 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Anat Cohen-Dayag
CHM | Chairman | 59 | 22/09/2025 |
Gilead Halevy
BRD | Director/Board Member | 59 | 10/06/2018 |
Sanford Zweifach
BRD | Director/Board Member | 70 | 10/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.88% | -9.82% | - | - | 201M | |
| -2.59% | -5.70% | +40.86% | +83.11% | 72.13B | |
| +3.23% | -13.45% | +6.00% | +55.77% | 49.41B | |
| +1.56% | +1.17% | +5.15% | +33.38% | 47.24B | |
| +0.68% | -7.74% | +300.39% | +648.51% | 40.32B | |
| +0.40% | +0.98% | +28.45% | +30.68% | 42.61B | |
| +1.17% | -0.70% | +5.88% | +105.78% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| +5.34% | +0.04% | -7.22% | -11.32% | 23.13B | |
| +3.78% | +8.33% | +18.40% | +0.33% | 21.09B | |
| Average | +0.82% | -3.91% | +45.05% | +110.73% | 40.7B | |
| Weighted average by Cap. | +0.71% | -4.28% | +47.77% | +118.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.24M 8.25M 7.68M 6.98M 13.18M 894M 13.24M 92.38M 36.2M 456M 34.69M 33.94M 1.46B | 7.75M 6.92M 6.44M 5.86M 11.06M 750M 11.11M 77.49M 30.36M 382M 29.1M 28.47M 1.23B |
| Net income | -26.46M -23.64M -21.99M -20M -37.76M -2.56B -37.92M -265M -104M -1.31B -99.38M -97.21M -4.19B | -26.95M -24.07M -22.39M -20.37M -38.45M -2.61B -38.62M -269M -106M -1.33B -101M -98.99M -4.27B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
